Replies to post #2165 on Repro Med Systems Inc (REPR)

[mrholty]

My thoughts exactly.

Another company can look at REPR and view the very good margins and see a way to take out half(?) of the SG&A spend. I'd argue that some will model up to 70% but I've never seen one actually be able to meet 50%.

Add in the fact that the product is useful to both a medical device company and to the drug mfgr's themselves potentially.